학술논문
Tolerability of Human Immunoglobulin 10% Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Primary Immunodeficiency Disease (PIDD) Patients
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology 2011 127(2) Supplement:AB15-AB15
Subject
Language
ISSN
0091-6749